Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
28S ribosomal protein S7, mitochondrial (MRPS7) is a structural protein encoded by the nuclear genome and localized to mitochondria, where it forms part of the small 28S subunit of the mitochondrial ribosome. MRPS7 is essential for mitochondrial protein synthesis and overall mitochondrial function. It participates in ribosome assembly and ensures fidelity of translation within the mitochondria. Mutations in the MRPS7 gene are associated with mitochondrial diseases, including combined oxidative phosphorylation deficiency and sensorineural deafness. MRPS7 itself is not directly targeted by drugs, but mitochondrial ribosomes as a whole may be affected by certain antibiotics and anti-cancer agents
None directly reported. - Drugs affecting the mitochondrial ribosome act broadly to inhibit mitochondrial protein synthesis and thus impair mitochondrial function, but no drugs act specifically via MRPS7
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal protein S7, mitochondrial (MRPS7).